Kaela Parkhouse

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 2

Top Topics

Insulin Resistance

Walled Carbon Nanotubes

Binding Protein

Top Venues

Science (New York, N.Y.)

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Claudia P Arevalo, Marcus J Bolton, Valerie Le Sage, Naiqing Ye, Colleen Furey, Hiromi Muramatsu, Mohamad-Gabriel Alameh, Norbert Pardi, Elizabeth M Drapeau, Kaela Parkhouse, Tyler Garretson, Jeffrey S Morris, Louise H Moncla, Ying K Tam, Steven H Y Fan, Seema S Lakdawala, Drew Weissman, Scott E Hensley
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes. Science (New York, N.Y.) 378 (6622) (2022)
Norbert Pardi, Michael J Hogan, Martin S Naradikian, Kaela Parkhouse, Derek W Cain, Letitia Jones, M Anthony Moody, Hans P Verkerke, Arpita Myles, Elinor Willis, Celia C LaBranche, David C Montefiori, Jenna L Lobby, Kevin O Saunders, Hua-Xin Liao, Bette T Korber, Laura L Sutherland, Richard M Scearce, Peter T Hraber, István Tombácz, Hiromi Muramatsu, Houping Ni, Daniel A Balikov, Charles Li, Barbara L Mui, Ying K Tam, Florian Krammer, Katalin Karikó, Patricia Polacino, Laurence C Eisenlohr, Thomas D Madden, Michael J Hope, Mark G Lewis, Kelly K Lee, Shiu-Lok Hu, Scott E Hensley, Michael P Cancro, Barton F Haynes, Drew Weissman
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. The Journal of experimental medicine 215 (6) (2018)